Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temazepam versus prolonged-release melatonin versus placebo for insomnia in adults with advanced cancer
ACTRN12620000581965Phase 3Not yet recruiting
- Sponsor
- Western Health
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Insomnia comparing Temazepam, Melatonin PR and Placebo (3 arms). Primary endpoint: Change in insomnia severity after 7 days. Planned start Jun 2020; status: not yet recruiting.
02
Drugs
temazepammelatonin
03
Conditions
Insomnia
Beyond the preview
Go deeper on ACTRN12620000581965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620000581965.